{"id":19699,"date":"2021-12-14T11:03:43","date_gmt":"2021-12-14T10:03:43","guid":{"rendered":"https:\/\/www.thema-med.com\/?p=19699"},"modified":"2023-02-14T09:42:58","modified_gmt":"2023-02-14T08:42:58","slug":"which-are-transitional-periods-designation-ch-rep","status":"publish","type":"post","link":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/","title":{"rendered":"Which are the transitional periods for the designation of the Swiss Authorised Representative CH REP?"},"content":{"rendered":"\r\n<p>According to Medical Devices Ordinance (MedDO) Article 104a, several <strong>transitional periods for the nominee of the <\/strong>Swiss<strong> Authorised Representative<\/strong> CH REP have been established based on the device risk class.<\/p>\r\n\r\n\r\n\r\n<p>The deadlines are given below:<\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li><strong>Within December 31, 2021,<\/strong> for Class III devices, Class IIb implantable devices, and active implantable Medical Devices.<\/li>\r\n<li><strong>Within March 31, 2022<\/strong>, for Class IIb non-implantable devices and Class IIa devices.<\/li>\r\n<li><strong>Within July 31, 2022,<\/strong> for Class I devices.<\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<p>Also, according to MedDO, <strong>Article 51<\/strong>, subparagraph a Swiss Authorised Representative CH REP for <strong>procedural kits and systems<\/strong> has to be designated by <strong>July 31, 2022.<\/strong><\/p>\r\n\r\n\r\n\r\n<p><strong><a href=\"https:\/\/www.thema-med.com\/en\/services\/\">Discover the strategic-regulatory consultancy services Thema<\/a><\/strong><\/p>\r\n\r\n\r\n\r\n\r\n\r\n<p>Do you want to stay updated on the main news regarding the Switzerland \u2013 EU Agreement in the field of Medical Devices?<\/p>\r\n\r\n\r\n\r\n<p>Fill out the form and receive periodically our <a href=\"https:\/\/md-24.us20.list-manage.com\/subscribe?u=672feff85a65d12563810beed&amp;id=3c9da60174\" target=\"_blank\" rel=\"noopener\">Newsletter<\/a>!<\/p>\r\n\r\n\r\n","protected":false},"excerpt":{"rendered":"<p>According to Medical Devices Ordinance (MedDO) Article 104a, several transitional periods for the nominee of the Swiss Authorised Representative CH REP  [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-19699","post","type-post","status-publish","format-standard","hentry","category-news-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Which are the transitional periods for the designation of the CH REP?<\/title>\n<meta name=\"description\" content=\"Several transitional periods for the nominee of the Swiss Authorised Representative CH REP have been established based on the device risk class.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Which are the transitional periods for the designation of the CH REP?\" \/>\n<meta property=\"og:description\" content=\"Several transitional periods for the nominee of the Swiss Authorised Representative CH REP have been established based on the device risk class.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/\" \/>\n<meta property=\"og:site_name\" content=\"Thema Med\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-14T10:03:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-14T08:42:58+00:00\" \/>\n<meta name=\"author\" content=\"redazione\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"redazione\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/\"},\"author\":{\"name\":\"redazione\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/8cb6614629bd6664e6f294690d35677e\"},\"headline\":\"Which are the transitional periods for the designation of the Swiss Authorised Representative CH REP?\",\"datePublished\":\"2021-12-14T10:03:43+00:00\",\"dateModified\":\"2023-02-14T08:42:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/\"},\"wordCount\":141,\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/\",\"url\":\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/\",\"name\":\"Which are the transitional periods for the designation of the CH REP?\",\"isPartOf\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\"},\"datePublished\":\"2021-12-14T10:03:43+00:00\",\"dateModified\":\"2023-02-14T08:42:58+00:00\",\"description\":\"Several transitional periods for the nominee of the Swiss Authorised Representative CH REP have been established based on the device risk class.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/www.thema-med.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Which are the transitional periods for the designation of the Swiss Authorised Representative CH REP?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"name\":\"Thema Med\",\"description\":\"Quality and Regulatory Affairs for Medical Devices\",\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thema-med.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"Place\"],\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\",\"name\":\"Thema\",\"alternateName\":\"Thema\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"contentUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"width\":2440,\"height\":2851,\"caption\":\"Thema\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/\"],\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/8cb6614629bd6664e6f294690d35677e\",\"name\":\"redazione\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b256f44c95829224dda80aff96bb893da058966fe2e8b7b58ece2b0d74ffa04d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b256f44c95829224dda80aff96bb893da058966fe2e8b7b58ece2b0d74ffa04d?s=96&d=mm&r=g\",\"caption\":\"redazione\"},\"sameAs\":[\"http:\/\/www.thema-med.eu\"],\"url\":\"https:\/\/www.thema-med.com\/en\/author\/emanuele\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Which are the transitional periods for the designation of the CH REP?","description":"Several transitional periods for the nominee of the Swiss Authorised Representative CH REP have been established based on the device risk class.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/","og_locale":"en_US","og_type":"article","og_title":"Which are the transitional periods for the designation of the CH REP?","og_description":"Several transitional periods for the nominee of the Swiss Authorised Representative CH REP have been established based on the device risk class.","og_url":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/","og_site_name":"Thema Med","article_published_time":"2021-12-14T10:03:43+00:00","article_modified_time":"2023-02-14T08:42:58+00:00","author":"redazione","twitter_card":"summary_large_image","twitter_misc":{"Written by":"redazione","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/#article","isPartOf":{"@id":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/"},"author":{"name":"redazione","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/8cb6614629bd6664e6f294690d35677e"},"headline":"Which are the transitional periods for the designation of the Swiss Authorised Representative CH REP?","datePublished":"2021-12-14T10:03:43+00:00","dateModified":"2023-02-14T08:42:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/"},"wordCount":141,"publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/","url":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/","name":"Which are the transitional periods for the designation of the CH REP?","isPartOf":{"@id":"https:\/\/www.thema-med.com\/en\/#website"},"datePublished":"2021-12-14T10:03:43+00:00","dateModified":"2023-02-14T08:42:58+00:00","description":"Several transitional periods for the nominee of the Swiss Authorised Representative CH REP have been established based on the device risk class.","breadcrumb":{"@id":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/www.thema-med.com\/en\/"},{"@type":"ListItem","position":2,"name":"Which are the transitional periods for the designation of the Swiss Authorised Representative CH REP?"}]},{"@type":"WebSite","@id":"https:\/\/www.thema-med.com\/en\/#website","url":"https:\/\/www.thema-med.com\/en\/","name":"Thema Med","description":"Quality and Regulatory Affairs for Medical Devices","publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thema-med.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","Place"],"@id":"https:\/\/www.thema-med.com\/en\/#organization","name":"Thema","alternateName":"Thema","url":"https:\/\/www.thema-med.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","contentUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","width":2440,"height":2851,"caption":"Thema"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/"],"mainEntityOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2021\/12\/14\/which-are-transitional-periods-designation-ch-rep\/"}},{"@type":"Person","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/8cb6614629bd6664e6f294690d35677e","name":"redazione","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b256f44c95829224dda80aff96bb893da058966fe2e8b7b58ece2b0d74ffa04d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b256f44c95829224dda80aff96bb893da058966fe2e8b7b58ece2b0d74ffa04d?s=96&d=mm&r=g","caption":"redazione"},"sameAs":["http:\/\/www.thema-med.eu"],"url":"https:\/\/www.thema-med.com\/en\/author\/emanuele\/"}]}},"_links":{"self":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/19699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/comments?post=19699"}],"version-history":[{"count":1,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/19699\/revisions"}],"predecessor-version":[{"id":27261,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/19699\/revisions\/27261"}],"wp:attachment":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/media?parent=19699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/categories?post=19699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/tags?post=19699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}